arrow
E

Elizabeth A. Coker

royal marsden nhs foundation trust
H指数:14
被引数:1,654

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
2022-10-148
OAAI
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes

基于人工智能的急性磷酸化蛋白质组学变化研究对NSCLC药物反应的个体化预测和合理联合治疗

2022-04-037
OAAI
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib
2021-02-0516
OAAI
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia
2020-12-1547
OAAI
Drug mechanism-of-action discovery through the integration of pharmacological andCRISPRscreens
2020-07-0659
OAAI